CANSF Willow Biosciences Inc.

Willow Biosciences, Inc. is a biotechnology company. It develops synthetic biology solutions for opioid biosynthesis. The firm offers biosynthetic production systems for plant-derived active pharmaceutical ingredients (API) and intermediates. The company was founded on April 12, 2019 and is headquartered in Calgary, Canada.

Note: This is not a U.S. company, but they cross-list their shares on the U.S. over-the-counter market - see the related symbol CT:WLLW.

$0.31    OTCQB
As of 01/26/2022     OTCMarkets


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Materials
Industry:  Drug Manufacturers—Specialty &
Index country:  Canada
Country of incorporation:  
IPO date:  01/12/2004
Outstanding shares:  123,545,323
Average volume:  27,594
Market cap:   $39,756,885
Current dividend yield:  0.00%
Sedol:      
Valuation   (See tab for details)
PE ratio:   -2.52
PB ratio:   1.33
PS ratio:   380.96
Return on equity:   -46.03%
Net income %:   -12,010.57%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy